Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Issued: 2011-2024

Historic Shares Issued for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $14.4 million.

  • Agios Pharmaceuticals' Shares Issued rose 68.18% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 4.92%. This contributed to the annual value of $14.4 million for FY2024, which is 165.82% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Shares Issued stood at $14.4 million for FY2024, which was up 165.82% from $5.4 million recorded in FY2023.
  • Agios Pharmaceuticals' Shares Issued's 5-year high stood at $37.3 million during FY2021, with a 5-year trough of $2.7 million in FY2022.
  • For the 3-year period, Agios Pharmaceuticals' Shares Issued averaged around $7.5 million, with its median value being $5.4 million (2023).
  • As far as peak fluctuations go, Agios Pharmaceuticals' Shares Issued crashed by 95.92% in 2020, and later spiked by 229.56% in 2021.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Shares Issued stood at $11.3 million in 2020, then skyrocketed by 229.56% to $37.3 million in 2021, then crashed by 92.81% to $2.7 million in 2022, then surged by 102.65% to $5.4 million in 2023, then surged by 165.82% to $14.4 million in 2024.